Amdocs (DOX) Competitors

SS&C Technologies pays an annual dividend of $1.20 per share and has a dividend yield of 1.5%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. SS&C Technologies pays out 34.5% of its earnings in the form of a dividend. Amdocs pays out 54.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SS&C Technologies has increased its dividend for 9 consecutive years and Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

SS&C Technologies has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, Amdocs has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

96.9% of SS&C Technologies shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 16.0% of SS&C Technologies shares are held by insiders. Comparatively, 15.4% of Amdocs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Amdocs had 3 more articles in the media than SS&C Technologies. MarketBeat recorded 6 mentions for Amdocs and 3 mentions for SS&C Technologies. Amdocs' average media sentiment score of 0.61 beat SS&C Technologies' score of 0.34 indicating that Amdocs is being referred to more favorably in the news media.

SS&C Technologies has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks.

SS&C Technologies presently has a consensus price target of $92.63, indicating a potential upside of 14.85%. Amdocs has a consensus price target of $86.67, indicating a potential upside of 43.87%. Given Amdocs' higher probable upside, analysts plainly believe Amdocs is more favorable than SS&C Technologies.

SS&C Technologies has a net margin of 13.16% compared to Amdocs' net margin of 9.75%. SS&C Technologies' return on equity of 21.20% beat Amdocs' return on equity.

Accenture presently has a consensus price target of $219.15, indicating a potential upside of 4.99%. Amdocs has a consensus price target of $86.67, indicating a potential upside of 43.87%. Given Amdocs' higher possible upside, analysts clearly believe Amdocs is more favorable than Accenture.

75.1% of Accenture shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 0.0% of Accenture shares are held by insiders. Comparatively, 15.4% of Amdocs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Accenture has a net margin of 11.28% compared to Amdocs' net margin of 9.75%. Accenture's return on equity of 26.53% beat Amdocs' return on equity.

Accenture has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market. Comparatively, Amdocs has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market.

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

In the previous week, Accenture had 51 more articles in the media than Amdocs. MarketBeat recorded 57 mentions for Accenture and 6 mentions for Amdocs. Accenture's average media sentiment score of 0.72 beat Amdocs' score of 0.61 indicating that Accenture is being referred to more favorably in the media.

Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 3.1%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. Accenture pays out 48.1% of its earnings in the form of a dividend. Amdocs pays out 54.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Accenture has increased its dividend for 20 consecutive years and Amdocs has increased its dividend for 14 consecutive years.

CGI Group pays an annual dividend of $0.48 per share and has a dividend yield of 0.7%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. CGI Group pays out 8.2% of its earnings in the form of a dividend. Amdocs pays out 54.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

CGI Group has a net margin of 10.54% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat CGI Group's return on equity.

66.7% of CGI Group shares are owned by institutional investors. Comparatively, 92.0% of Amdocs shares are owned by institutional investors. 9.9% of CGI Group shares are owned by company insiders. Comparatively, 15.4% of Amdocs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CGI Group has higher revenue and earnings than Amdocs. CGI Group is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

In the previous week, Amdocs had 1 more articles in the media than CGI Group. MarketBeat recorded 6 mentions for Amdocs and 5 mentions for CGI Group. Amdocs' average media sentiment score of 0.61 beat CGI Group's score of 0.23 indicating that Amdocs is being referred to more favorably in the news media.

CGI Group currently has a consensus target price of $83.67, suggesting a potential upside of 20.07%. Amdocs has a consensus target price of $86.67, suggesting a potential upside of 43.87%. Given Amdocs' stronger consensus rating and higher probable upside, analysts plainly believe Amdocs is more favorable than CGI Group.

CGI Group has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market.

2.4% of Wipro shares are owned by institutional investors. Comparatively, 92.0% of Amdocs shares are owned by institutional investors. 1.0% of Wipro shares are owned by insiders. Comparatively, 15.4% of Amdocs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Wipro has higher revenue and earnings than Amdocs. Wipro is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

In the previous week, Amdocs had 2 more articles in the media than Wipro. MarketBeat recorded 6 mentions for Amdocs and 4 mentions for Wipro. Amdocs' average media sentiment score of 0.61 beat Wipro's score of 0.14 indicating that Amdocs is being referred to more favorably in the news media.

Wipro has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

Wipro pays an annual dividend of $0.04 per share and has a dividend yield of 2.4%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. Wipro pays out 30.8% of its earnings in the form of a dividend. Amdocs pays out 54.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Wipro has a net margin of 13.93% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat Wipro's return on equity.

Wipro presently has a consensus price target of $1.70, suggesting a potential upside of 2.10%. Amdocs has a consensus price target of $86.67, suggesting a potential upside of 43.87%. Given Amdocs' stronger consensus rating and higher probable upside, analysts plainly believe Amdocs is more favorable than Wipro.